본문

  1. Home
154 Results:AA:BELL G 0.124 sec.
RSS 
Multilingual
 Расширенный поиск
 Новый поиск книги прибытия
Selected Print Select Export to Excel
21
Estrogen deficiency increases osteoclastogenesis up-regulating T cells activity: A key mechanism in osteoporosis
Estrogen deficiency increases osteoclastogenesis up-regulating T cells activity: A key mechanism in osteoporosis
D'Amelio Patrizia,, | Elsevier Inc | 2008 ,
22
The endovanilloid/endocannabinoid system in human osteoclasts: Possible involvement in bone formation and resorption
The endovanilloid/endocannabinoid system in human osteoclasts: Possible involvement in bone formation and resorption
Rossi, F., | Elsevier Inc | 2009 ,
23
Improvement of Anselme's adhesion model for evaluating human osteoblast response to peptide-grafted titanium surfaces
Improvement of Anselme's adhesion model for evaluating human osteoblast response to peptide-grafted titanium surfaces
Bagno, A., | Elsevier Inc | 2007 ,
24
WISE-2005: Bed-rest induced changes in bone mineral density in women during 60days simulated microgravity
WISE-2005: Bed-rest induced changes in bone mineral density in women during 60days simulated microgravity
Beller, G., | Elsevier Inc | 2011 ,
25
Role of iron metabolism and oxidative damage in postmenopausal bone loss
Role of iron metabolism and oxidative damage in postmenopausal bone loss
D'Amelio, P., | Elsevier Inc | 2008 ,
26
Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo
Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo
Rhee, Y., | Elsevier Inc | 2011 ,
27
Nitrogen-containing bisphosphonates can inhibit angiogenesis in vivo without the involvement of farnesyl pyrophosphate synthase
Nitrogen-containing bisphosphonates can inhibit angiogenesis in vivo without the involvement of farnesyl pyrophosphate synthase
Verena Stresing,, | Elsevier Inc | 2011 ,
28
ATF936, a novel oral calcilytic, increases bone mineral density in rats and transiently releases parathyroid hormone in humans
ATF936, a novel oral calcilytic, increases bone mineral density in rats and transiently releases parathyroid hormone in humans
John, M. R., | Elsevier Inc | 2011 ,
29
The endovanilloid/endocannabinoid system: A new potential target for osteoporosis therapy
The endovanilloid/endocannabinoid system: A new potential target for osteoporosis therapy
Endocannabinoid Research Group (ERG), I, | Elsevier Inc | 2011 ,
30
A bisphosphonate that does not affect osteoclasts prevents osteoblast and osteocyte apoptosis and the loss of bone strength induced by glucocorticoids in mice
A bisphosphonate that does not affect osteoclasts prevents osteoblast and osteocyte apoptosis and the loss of bone strength induced by glucocorticoids in mice
Plotkin, L. I., | Elsevier Inc | 2011 ,
처음이전12345678910이후마지막